Network-based analysis of the sphingolipid metabolism in hypertension

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Network-based analysis of the sphingolipid metabolism in hypertension. / Fenger, Mogens; Linneberg, Allan; Jeppesen, Jørgen.

I: Frontiers in Genetics, Bind 6, 84, 03.2015, s. 1-14.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Fenger, M, Linneberg, A & Jeppesen, J 2015, 'Network-based analysis of the sphingolipid metabolism in hypertension', Frontiers in Genetics, bind 6, 84, s. 1-14. https://doi.org/10.3389/fgene.2015.00084

APA

Fenger, M., Linneberg, A., & Jeppesen, J. (2015). Network-based analysis of the sphingolipid metabolism in hypertension. Frontiers in Genetics, 6, 1-14. [84]. https://doi.org/10.3389/fgene.2015.00084

Vancouver

Fenger M, Linneberg A, Jeppesen J. Network-based analysis of the sphingolipid metabolism in hypertension. Frontiers in Genetics. 2015 mar.;6:1-14. 84. https://doi.org/10.3389/fgene.2015.00084

Author

Fenger, Mogens ; Linneberg, Allan ; Jeppesen, Jørgen. / Network-based analysis of the sphingolipid metabolism in hypertension. I: Frontiers in Genetics. 2015 ; Bind 6. s. 1-14.

Bibtex

@article{44deec9647904ba8a07225a63b80716a,
title = "Network-based analysis of the sphingolipid metabolism in hypertension",
abstract = "Common diseases like essential hypertension or diabetes mellitus are complex as they are polygenic in nature, such that each genetic variation only has a small influence on the disease. Genes operates in integrated networks providing the blue-print for all biological processes and conditional of the complex genotype determines the state and dynamics of any trait, which may be modified to various extent by non-genetic factors. Thus, diseases are heterogenous ensembles of conditions with a common endpoint. Numerous studies have been performed to define genes of importance for a trait or disease, but only a few genes with small effect have been identified. The major reasons for this modest progress is the unresolved heterogeneity of the regulation of blood pressure and the shortcomings of the prevailing monogenic approach to capture genetic effects in a polygenic condition. Here, a two-step procedure is presented in which physiological heterogeneity is disentangled and genetic effects are analyzed by variance decomposition of genetic interactions and by an information theoretical approach including 162 single nucleotide polymorphisms (SNP) in 84 genes in the sphingolipid metabolism and related networks in blood pressure regulation. As expected, almost no genetic main effects were detected. In contrast, two-gene interactions established the entire sphingolipid metabolic and related genetic network to be highly involved in the regulation of blood pressure. The pattern of interaction clearly revealed that epistasis does not necessarily reflects the topology of the metabolic pathways i.e., the flow of metabolites. Rather, the enzymes and proteins are integrated in complex cellular substructures where communication flows between the components of the networks, which may be composite in structure. The heritabilities for diastolic and systolic blood pressure were estimated to be 0.63 and 0.01, which may in fact be the maximum heritabilities of these traits. This procedure provide a platform for studying and capturing the genetic networks of any polygenic trait, condition, or disease.",
author = "Mogens Fenger and Allan Linneberg and J{\o}rgen Jeppesen",
year = "2015",
month = mar,
doi = "10.3389/fgene.2015.00084",
language = "English",
volume = "6",
pages = "1--14",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Network-based analysis of the sphingolipid metabolism in hypertension

AU - Fenger, Mogens

AU - Linneberg, Allan

AU - Jeppesen, Jørgen

PY - 2015/3

Y1 - 2015/3

N2 - Common diseases like essential hypertension or diabetes mellitus are complex as they are polygenic in nature, such that each genetic variation only has a small influence on the disease. Genes operates in integrated networks providing the blue-print for all biological processes and conditional of the complex genotype determines the state and dynamics of any trait, which may be modified to various extent by non-genetic factors. Thus, diseases are heterogenous ensembles of conditions with a common endpoint. Numerous studies have been performed to define genes of importance for a trait or disease, but only a few genes with small effect have been identified. The major reasons for this modest progress is the unresolved heterogeneity of the regulation of blood pressure and the shortcomings of the prevailing monogenic approach to capture genetic effects in a polygenic condition. Here, a two-step procedure is presented in which physiological heterogeneity is disentangled and genetic effects are analyzed by variance decomposition of genetic interactions and by an information theoretical approach including 162 single nucleotide polymorphisms (SNP) in 84 genes in the sphingolipid metabolism and related networks in blood pressure regulation. As expected, almost no genetic main effects were detected. In contrast, two-gene interactions established the entire sphingolipid metabolic and related genetic network to be highly involved in the regulation of blood pressure. The pattern of interaction clearly revealed that epistasis does not necessarily reflects the topology of the metabolic pathways i.e., the flow of metabolites. Rather, the enzymes and proteins are integrated in complex cellular substructures where communication flows between the components of the networks, which may be composite in structure. The heritabilities for diastolic and systolic blood pressure were estimated to be 0.63 and 0.01, which may in fact be the maximum heritabilities of these traits. This procedure provide a platform for studying and capturing the genetic networks of any polygenic trait, condition, or disease.

AB - Common diseases like essential hypertension or diabetes mellitus are complex as they are polygenic in nature, such that each genetic variation only has a small influence on the disease. Genes operates in integrated networks providing the blue-print for all biological processes and conditional of the complex genotype determines the state and dynamics of any trait, which may be modified to various extent by non-genetic factors. Thus, diseases are heterogenous ensembles of conditions with a common endpoint. Numerous studies have been performed to define genes of importance for a trait or disease, but only a few genes with small effect have been identified. The major reasons for this modest progress is the unresolved heterogeneity of the regulation of blood pressure and the shortcomings of the prevailing monogenic approach to capture genetic effects in a polygenic condition. Here, a two-step procedure is presented in which physiological heterogeneity is disentangled and genetic effects are analyzed by variance decomposition of genetic interactions and by an information theoretical approach including 162 single nucleotide polymorphisms (SNP) in 84 genes in the sphingolipid metabolism and related networks in blood pressure regulation. As expected, almost no genetic main effects were detected. In contrast, two-gene interactions established the entire sphingolipid metabolic and related genetic network to be highly involved in the regulation of blood pressure. The pattern of interaction clearly revealed that epistasis does not necessarily reflects the topology of the metabolic pathways i.e., the flow of metabolites. Rather, the enzymes and proteins are integrated in complex cellular substructures where communication flows between the components of the networks, which may be composite in structure. The heritabilities for diastolic and systolic blood pressure were estimated to be 0.63 and 0.01, which may in fact be the maximum heritabilities of these traits. This procedure provide a platform for studying and capturing the genetic networks of any polygenic trait, condition, or disease.

U2 - 10.3389/fgene.2015.00084

DO - 10.3389/fgene.2015.00084

M3 - Journal article

C2 - 25788903

VL - 6

SP - 1

EP - 14

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

M1 - 84

ER -

ID: 161584721